Ülke: Yeni Zelanda
Dil: İngilizce
Kaynak: Medsafe (Medicines Safety Authority)
Ethinylestradiol 20ug; Levonorgestrel 100ug; Ethinylestradiol 0.02mg; Levonorgestrel 0.1mg
Pfizer New Zealand Limited
Ethinylestradiol 20 µg
Film coated tablet
Active: Ethinylestradiol 20ug Levonorgestrel 100ug Excipient: Glycol montanate Lactose monohydrate Macrogols Magnesium stearate Microcrystalline cellulose Opadry pink YS-1-14587-A Polacrilin potassium Glycol montanate Lactose monohydrate Macrogol 1500 Magnesium stearate Microcrystalline cellulose Opadry white Y-5-18024-A Polacrilin potassium AquaPolish P white 010.66 Magnesium stearate StarLac Active: Ethinylestradiol 0.02mg Levonorgestrel 0.1mg Excipient: Wax E Pharma Lactose Magnesium stearate Microcrystalline cellulose Opadry pink YS-1-14587-A Polacrilin potassium Polyethylene glycol 1450 Purified water Wax E Pharma Lactose Macrogol 1500 Magnesium stearate Microcrystalline cellulose Opadry white Y-5R-18024-A Polacrilin potassium Purified water
Calendar pack, PVC/AL 1x28 tablets starter pack, 28 tablets
Prescription
Prescription
Bayer AG
LOETTE is indicated for the prevention of pregnancy.
Package - Contents - Shelf Life: Calendar pack, PVC/AL 1x28 tablets starter pack Pfizer Ireland - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Calendar pack, PVC/AL 1x28 tablets starter pack inside Al foil pouch with desiccant Haupt Pharma Munster GmbH - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Calendar pack, PVC/AL 3x28 tablets Pfizer Ireland - 84 tablets - 24 months from date of manufacture stored at or below 25°C - Calendar pack, PVC/AL 3x28 tablets inside Al foil pouch with desiccant Haupt Pharma Munster GmbH - 84 tablets - 24 months from date of manufacture stored at or below 25°C
1996-12-13
LOETTE ® PAGE 1 OF 8 LOETTE ® _Levonorgestrel and Ethinylestradiol Tablets_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Loette. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Loette against the benefits this medicine is expected to have for you. IF YOU HAVE ANY QUESTIONS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT LOETTE IS USED FOR Loette is an oral contraceptive, commonly known as a “birth control pill” or “the Pill”. Loette tablets contain two hormones (levonorgestrel and ethinylestradiol), which prevent you from becoming pregnant if taken correctly. They are similar to the hormones that your body normally produces. Loette prevents pregnancy in several ways: It inhibits the egg release by stopping it maturing It changes the cervical mucus consistency making it difficult for the sperm to reach the egg It changes the lining of the uterus making it less suitable for implantation. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY LOETTE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed Loette for another reason. This medicine is available only with a doctor's prescription. Loette is not habit-forming. This medicine is not expected to affect your ability to drive a car or operate machinery. BEFORE YOU TAKE LOETTE _WHEN YOU MUST NOT TAKE _ _LOETTE_ DO NOT TAKE LOETTE IF YOU HAVE AN ALLERGY TO: Any medicine containing ethinylestradiol or levonorgestrel Any of the ingredients listed at the end of this leaflet Any other similar medicines (such as other oral contraceptives) Some of the symptoms of an allergic reaction may include: shortness of breath wheezing or difficulty breathing swelling of the face, lips, tongue or other parts of the body rash, itching Belgenin tamamını okuyun
Version: pfdloett11118 Supersedes: pfdloett10518 Page 1 of 18 NEW ZEALAND DATA SHEET 1. PRODUCT NAME LOETTE 20 µg and 100 µg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 20 µg Ethinylestradiol and 100 µg Levonorgestrel Excipients with known effects: • Lactose monohydrate For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Each LOETTE calendar blister pack contains 21 pink active tablets and 7 white inactive tablets. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS LOETTE is indicated for the prevention of pregnancy. 4.2 DOSE AND METHOD OF ADMINISTRATION HOW TO TAKE LOETTE To achieve maximum contraceptive effectiveness, LOETTE must be administered as directed and at the same time every day, at intervals not exceeding 24 hours. HOW TO START LOETTE Each package of LOETTE contains 21 active pink tablets and 7 white inactive tablets. NO PRECEDING HORMONAL CONTRACEPTIVE USE (IN THE PAST MONTH) On the first day of the menstrual cycle, i.e. the first day of bleeding, the woman is instructed to take a pink active tablet corresponding to that day of the week from the pink shaded section of the LOETTE pack. Thereafter, one pink active tablet is taken daily, following the arrows marked on the package, until all 21 pink active tablets have been taken. The woman is then instructed to take one white inactive tablet daily for the next seven days following the arrows marked on the LOETTE pack. Withdrawal bleeding should usually occur within 2 to 4 days after the last pink active tablet is taken. LOETTE is effective from the first day of therapy if the tablets are begun on Day 1 as described. Starting on Days 2-7 is allowed, but during the first cycle a back-up method of contraception is recommended for the first 7 days of tablet taking. Version: pfdloett11118 Supersedes: pfdloett10518 Page 2 of 18 The back-up method of contraception must be an additional non-hormonal barrier method such as condoms or a diaphragm with a spermicide. Back-up contraception does not include Belgenin tamamını okuyun